BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 23, 2025
Home » Authors » John Fox

John Fox

Articles

ARTICLES

Chinese-U.S. study provides clues to treating aging disorders

May 6, 2015
By John Fox
HONG KONG – The findings of a Sino-U.S. study that links the aging process to the deterioration of heterochromatin could lead to methods of preventing and/or treating age-related diseases including cancer, diabetes and Alzheimer's disease, researchers reported in the May 1, 2015, issue of Science.
Read More

Chinese-U.S. study provides clues to treating aging disorders

May 5, 2015
By John Fox
HONG KONG – The findings of a Sino-U.S. study that links the aging process to the deterioration of heterochromatin could lead to methods of preventing and/or treating age-related diseases including cancer, diabetes and Alzheimer's disease, researchers reported in the May 1, 2015, issue of Science.
Read More

Novel brown fat regulation target identified in Singapore

April 29, 2015
By John Fox
HONG KONG – A study by researchers at the Duke-National University of Singapore Graduate Medical School (Duke-NUS) has identified a new means by which brown adipose tissue is regulated in the body, which offers an attractive new target for the development of new obesity treatments.
Read More

Novel brown fat regulation target identified in Singapore

April 28, 2015
By John Fox
HONG KONG – A study by researchers at the Duke-National University of Singapore Graduate Medical School (Duke-NUS) has identified a new means by which brown adipose tissue is regulated in the body, which offers an attractive new target for the development of new anti-obesity treatments.
Read More

Genomic, functional analyses point way to new glioma therapy

April 27, 2015
By John Fox
HONG KONG – The discovery of cancer-associated functions of a ligase enzyme and the gene encoding for it by researchers from Singapore, China and the U.S. may lead to the development of a new approach to the treatment of glioma.
Read More

Genomic, functional analyses point way to new glioma therapy

April 22, 2015
By John Fox
HONG KONG —The discovery of cancer-associated functions of a ligase enzyme and the gene encoding for it by researchers from Singapore, China and the U.S. may lead to the development of a new approach to the treatment of glioma.
Read More

Receptor finding may lead to new diabetes drugs, study says

April 15, 2015
By John Fox
HONG KONG – Japanese scientists have used an advanced high-energy radiation particle accelerator to elucidate the structure of two receptors of the adipocyte-derived hormone, adiponectin, which could lead to the development of new treatments for obesity-related diseases, in particular type 2 diabetes.
Read More

Receptor finding may lead to new diabetes drugs, study says

April 15, 2015
By John Fox
HONG KONG – Japanese scientists have used an advanced high-energy radiation particle accelerator to elucidate the structure of two receptors of the adipocyte-derived hormone, adiponectin, which could lead to the development of new treatments for obesity-related diseases, in particular type 2 diabetes.
Read More

Key GPC finding opens door to drug discovery

April 8, 2015
By John Fox
HONG KONG – A Sino-U.S. research collaboration has determined the atomic structure of the G protein-coupled (GPC) P2Y1 receptor, which plays a key role in thrombus formation, challenging conventional concepts of drug action at GPC receptors and opening the door for future new drug discovery and development.
Read More

Key GPC finding opens door to drug discovery

April 8, 2015
By John Fox
HONG KONG – A Sino-U.S. research collaboration has determined the atomic structure of the G protein-coupled (GPC) P2Y1 receptor, which plays a key role in thrombus formation, challenging conventional concepts of drug action at GPC receptors and opening the door for future new drug discovery and development.
Read More
View All Articles by John Fox

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 22, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 22, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing